Physician profile
James Lebolt
NPI 1245331941
$13,522.05
in general payments reported to CMS, 2019-2025
12 companies · $2,855 in 2025
The $2,855 reported for 2025 was more than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,284 · 2020: $1,322 · 2021: $344 · 2022: $2,205 · 2023: $2,273 · 2024: $3,240 · 2025: $2,855.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,850 · Food and Beverage: $3,518.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,849.55 |
| Food and Beverage | $3,517.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $8,898.80 | 2019-2025 | Arthrex |
| Zimmer Biomet Holdings, INC. | $1,467.80 | 2023-2025 | Avenir, Tapestry, Persona |
| Medwest Associates | $1,135.69 | 2020-2023 | |
| Lightbody Medical Technologies INC | $592.38 | 2024 | |
| Stryker Corporation | $551.75 | 2024-2025 | System 9 Cd Nxt, Insignia, Mako |
| Zak Ortho | $237.37 | 2024-2025 | |
| Smith+Nephew, INC. | $217.16 | 2019-2025 | Spatial Frame, Bone Anchors With Arthroscopic Delivery System |
| Djo, LLC | $132.69 | 2023 | Donjoy, Aircast |
| Conmed Corporation | $120.30 | 2020 | |
| Depuy Synthes Sales INC. | $116.14 | 2019 | |
| Ferring Pharmaceuticals INC. | $27.67 | 2022-2023 | Euflexxa |
| Medtronic, INC. | $24.30 | 2024 | Mazor X System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lebolt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.